Cargando…
Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a pandemic in many countries around the world. The virus is highly contagious and has a high fatality rate. Lung adenocarcinoma (LUAD) patients may have higher suscepti...
Autores principales: | Zhang, Wentao, Yang, Zhe, Zhou, Fengge, Wei, Yanjun, Ma, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493477/ https://www.ncbi.nlm.nih.gov/pubmed/36157452 http://dx.doi.org/10.3389/fendo.2022.935906 |
Ejemplares similares
-
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC
por: Wu, Wen-yu, et al.
Publicado: (2023) -
SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
por: Zhang, Yanli, et al.
Publicado: (2022) -
Melatonin: Multi-Target Mechanism Against Diminished Ovarian Reserve Based on Network Pharmacology
por: Yang, Liuqing, et al.
Publicado: (2021) -
Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022) -
Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes
por: Wu, Ming, et al.
Publicado: (2022)